Keyphrases
Toxoplasma Gondii (T. gondii)
100%
MAP Kinase Phosphatase
25%
Apicomplexan
25%
Enoyl Acyl Carrier Protein Reductase
25%
Immune Response
22%
Liposomes
21%
Arginase-1 (Arg-1)
19%
Apicomplexan Parasites
18%
Triclosan
16%
Step Change
16%
Self-amplifying RNA Vaccine
16%
Cellular Uptake
16%
Balb C Mice
16%
Macrophages
16%
Host Cell
15%
Toxoplasmosis
14%
Cationic Lipids
14%
Cationic Liposomes
13%
Toxoplasma Gondii Infection
13%
Small Activating RNA (saRNA)
12%
Protective Behavior
11%
Dimethyldioctadecylammonium
11%
Inducible Nitric Oxide Synthase
11%
Nonionic Surfactant
11%
Biodistribution
11%
Antibiotics
11%
Reductase Enzymes
10%
Delivery System
10%
Interleukin-6
10%
Tachyzoite
10%
CD8+ T Cells
10%
Virus
10%
Specific Antibodies
10%
Immunogenicity
9%
Trimethylammonium
9%
Propane
9%
Adjuvanted
9%
Monocyte Chemoattractant protein-1 (MCP-1)
9%
Bradyzoite
9%
IC50
9%
C57BL
9%
Hyporesponsiveness
8%
Disease Phenotype
8%
Cationic Lipid Nanoparticles
8%
Healers
8%
Diarylethene
8%
Subunit Vaccine
8%
Benzimidazole
8%
Enzyme Targets
8%
Antigen-specific Antibody
8%
Pharmacology, Toxicology and Pharmaceutical Science
Toxoplasma gondii
42%
Liposome
25%
Oxidoreductase
25%
Infection
22%
Apicomplexan Infection
19%
IC50
19%
Triclosan
16%
Biodistribution
14%
Apicomplexa
14%
Solid Lipid Nanoparticle
12%
Antibiotics
12%
Acyl Carrier Protein
11%
Toxoplasmosis
11%
Nanoparticle
9%
1,2 Dioleoyl 3 Trimethylammoniopropane
9%
Adjuvant
9%
Antibodies
9%
mRNA Vaccine
8%
Benzimidazole
8%
Subunit Vaccine
8%
Salicylanilide Derivative
8%
Dicetyl Phosphate
8%
Glycerophosphate
8%
Melioidosis
8%
Anura
8%
Biological Activity
8%
Microbiome
8%
Protein Corona
8%
Melanoma
8%
Zein
8%
Malignant Neoplasm
8%
Micelle
8%
Drug Development
8%
Levofloxacin
6%
Infectious Agent
6%
Vaccine Efficacy
6%
Coenzyme Q - Cytochrome C Reductase
5%
Drug Delivery System
5%
Tachyzoite
5%
Bradyzoite
5%
Lead Compound
5%
Plasmodium falciparum
5%
Cytochrome B
5%
Dimethyldioctadecylammonium Bromide
5%
Vaccine Adjuvant
5%
Immunology and Microbiology
Toxoplasma gondii
53%
Macrophage
30%
Immune Response
21%
Bagg Albino Mouse
16%
Toxoplasmosis
16%
Cytotoxic T-Cell
13%
Parasite Load
13%
Transgenic Mouse
11%
Multi-Omics
10%
Interleukin 6
10%
TLR4
9%
Peptides
9%
T Cell
9%
Encephalitis
9%
Arginine
9%
Wild Type
8%
RNA Vaccine
8%
C57BL 6 Mouse
8%
Dendritic Cell
8%
Molecular Model
8%
Oocyst
8%
Inflammatory Arthritis
8%
Immunogenetics
8%
HLA A11 Antigen
8%
Bone Marrow Derived Dendritic Cell
8%
Epitope
8%
Leishmania Major
8%
Major Histocompatibility Complex
8%
Interleukin 12
8%
Monocyte Chemotactic Protein 1
8%
Neutrophil
8%
Virus
8%
Blood Brain Barrier
8%
Toxoplasma
8%
Infectious Agent
8%
Mitogen
7%
Host Cell
7%
Tachyzoite
7%
Acanthamoeba
6%
Coated Vesicle
6%
Wild Type Mouse
5%
Attenuated Vaccine
5%
Live Vaccine
5%
Peptide Vaccine
5%
